Background and aims To investigate the effect of Bryophyllum pinnatum extract to B cells by supressing maturation and increasing apoptosis of B cells.
Methods In silico study was done to understand affinity of Bryophillin A, Bryophillin B, Bryotoxin A, Bryotoxin B, Kaempferol, p-coumaric acid aiffinity in Bryophyllum pinnatum against B cell activating factor (BAFF) and its receptors: B cell activating factor receptors (BAFF-R), transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), and B-cell maturation antigen (BCMA). In vitro study was done by culturing B cells from pristane induced lupus BALB/c mice’s spleen. B cells were cultured into four groups, one as a control and the other groups given Bryophyllum pinnatum extract (0.02, 0.1, and 0.5 ug/L). Precentage of maturation (CD19+/CD38+) and apoptosis (Annexin V+/PI+) of B cells determined using flow cytometry. Immunocytochemistry assay was performed to determine the expression of transcription factor NF-kB p65.
Results Molecular docking results show that all of Bryophyllum pinnatum compounds studied have affinities for BAFF-R, TACI, BCMA and BAFF. Flow cytometry assay showed significantly decrease in percentages of maturation of B cells in all doses (p<0.05), significantly increase in percentages of apoptotic B cells in dose 0.5 ug/L (p<0.05). The results of immunocytochemistry showed decreased expression of NF-kB p65 were significant at all doses (p<0.05).
Conclusions In silico and in vitro study revealed that Bryophyllum pinnatum is potential natural product which may be used for B cell depleting agent in development of biosimilar therapy in systemic lupus erythematosus.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.